PhaseRx is a biopharmaceutical company developing a portfolio of mRNA products to correct inherited, life-threatening liver diseases in children. PhaseRx expert scientists are passionately committed to making a positive social impact by reducing serious medical problems and fatalities caused by these rare diseases.
410 West Harrison Street Suite 300 Seattle WA 98119
Office: 206.805.6300